Scholars@Duke

NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center

Clinical Trial Grant
Duke Scholars
Glenn Jay Jaffe
Principal Investigator Glenn Jay Jaffe Ophthalmology, Vitreoretinal Diseases & Surgery
Sina Farsiu
Co-Principal Investigator Sina Farsiu Biomedical Engineering

Administered By

Ophthalmology

Awarded By

National Institutes of Health

Start Date

March 17, 2022

End Date

February 28, 2027
 

Administered By

Ophthalmology

Awarded By

National Institutes of Health

Start Date

March 17, 2022

End Date

February 28, 2027